DIY HRT: Why Women Are Doing It, and Why It's a Gamble
DIY HRT is a symptom of a broken system, not a character flaw — but the risks of doing it without monitoring are real and specific.
Estrogen without adequate progesterone protection puts your endometrium at risk. OTC cream is not the same as pharmaceutical-grade micronized progesterone.
The 2002 WHI study that scared everyone off HRT has been substantially revised. Timing, route, and hormone type all matter more than the old headlines suggested.
Feeling better is not the same as being safe. Without labs, you have no feedback loop.
Transdermal estrogen has a dramatically lower clot risk than oral estrogen. Route of delivery is not a minor detail.
The goal isn't to avoid hormones — it's to use them with enough clinical oversight that the benefit actually outweighs the risk for your specific biology.
Supervised hormone therapy starts with your labs, not a protocol someone else is using on a forum.
The Underground Hormone Movement Nobody's Talking About Officially
Scroll through any perimenopause subreddit or women's health Facebook group for ten minutes and you'll find it: threads of women sharing estradiol patch brands, progesterone dosing schedules, and tips for ordering hormone creams from overseas pharmacies. This is DIY HRT — self-managed hormone therapy — and it's not a fringe phenomenon. It's a quiet, sprawling response to a healthcare system that has, for decades, left women's hormonal health woefully underserved.
The frustration driving it is real. You go to your GP with hot flashes, brain fog, and a sleep schedule that's completely fallen apart, and you get told "that's just menopause" or handed an antidepressant. So women turn to each other, to online pharmacies, to unregulated creams bought from wellness shops — because something is better than nothing. Right?
Here's the honest answer: sometimes, yes. But the risks of getting this wrong are not trivial. This article breaks down why DIY HRT happens, what the actual dangers look like, and what medically supervised hormone therapy — the kind that's calibrated to your labs, your history, and your goals — actually looks like in practice.
What DIY HRT Actually Means
DIY HRT (do-it-yourself hormone replacement therapy) refers to using estrogen, progesterone, testosterone, or combinations of these hormones without a prescribing clinician actively monitoring your treatment. The spectrum is wide. At one end, it's ordering a bioidentical progesterone cream from a wellness brand and applying it based on advice from a forum. At the other end, it's sourcing pharmaceutical-grade estradiol patches from an online pharmacy in another country and self-prescribing based on your own research.
The term "bioidentical" is worth unpacking here, because it's thrown around a lot and means different things depending on who's using it. Bioidentical hormones are chemically identical to the hormones your body produces — estradiol, progesterone, testosterone. That's distinct from synthetic hormones like medroxyprogesterone acetate (a progestin used in older HRT formulations that carries a different risk profile). Bioidentical doesn't automatically mean safe, and it definitely doesn't mean "no monitoring needed."
Think of it this way: insulin is also bioidentical. That doesn't mean you'd self-dose it without a prescriber.
Why Women Are Going the DIY Route
This isn't recklessness. It's a rational response to systemic failure. A few things are driving it:
- Provider gatekeeping: Many GPs are still operating off outdated guidance from the 2002 Women's Health Initiative study, which overstated the risks of HRT (particularly for breast cancer) in ways that have since been significantly revised and contextualized. Women are being turned away from hormone therapy that current evidence supports.
- Access and cost: In the US, a hormone consultation, labs, and a prescription can easily run $300-$500 out of pocket if you're not insured for it. Ordering from abroad or buying OTC progesterone cream costs a fraction of that.
- Information abundance: Menopause specialists like Dr. Mary Claire Haver, Dr. Jen Gunter, and online communities have educated women in unprecedented detail about their hormonal options. The knowledge gap between patient and provider has narrowed — sometimes past the point where the patient trusts the provider at all.
- Desperation: Severe symptoms — debilitating hot flashes, genitourinary syndrome, cognitive changes, mood instability — create urgency. When the system says "wait and see," some women decide they can't afford to wait.
All of this is understandable. But understanding why it happens doesn't mean pretending the risks don't exist.
The Real Risks of Unmonitored Hormone Therapy
Let's be specific, because "risks" is a word that gets weaponized to scare women away from hormones they'd genuinely benefit from. The risks of DIY HRT are distinct from the (often exaggerated) risks of supervised HRT.
Unopposed estrogen and endometrial risk
This is the big one. If you have a uterus, taking estrogen without adequate progesterone significantly raises your risk of endometrial hyperplasia — a thickening of the uterine lining that, left unchecked, can progress to endometrial cancer. Research consistently shows that progesterone counterbalances estrogen's proliferative effect on the uterine lining. In supervised HRT, this is routine — if you have a uterus, you get both. In DIY protocols, it's easy to get wrong: using an OTC progesterone cream that delivers insufficient systemic levels, or cycling estrogen without understanding the timing of progesterone coverage.
Progesterone creams sold over the counter are not the same as pharmaceutical-grade micronized progesterone. Many OTC creams don't deliver enough progesterone to adequately protect the endometrium. Women using them believing they're "covered" may not be.
Dosing in the dark
Hormone response is highly individual. Your body's baseline estradiol levels, your liver's metabolism of estrogen, your sensitivity to progesterone — all of these affect how you respond to a given dose. Without labs, you're guessing. You might be under-dosing and getting no benefit. You might be over-dosing and driving up levels that increase clot risk or worsen hormone-sensitive conditions. Either way, you won't know.
Drug interactions and contraindications you might not know you have
HRT interacts with several medications — anticoagulants, thyroid medications, some antiepileptics. And certain conditions are contraindications: active or recent hormone-receptor-positive breast cancer, a history of certain clotting disorders, undiagnosed vaginal bleeding. Without a clinical history review, you're flying blind on whether any of these apply to you.
Unregulated products
Not all of what's sold as "bioidentical hormone cream" or "natural progesterone" actually contains what it says it does at the concentration advertised. Compounded products especially vary widely in quality depending on the pharmacy. Pharmaceutical-grade products from a licensed pharmacy with a valid prescription carry quality controls that the wellness-market alternatives don't.
What the Evidence Actually Says About HRT
Here's where it helps to separate the science from the decades of fear-based messaging. The 2002 WHI study caused a massive drop in HRT use when it reported increased risks of breast cancer, heart disease, and stroke. What's been established since then is considerably more nuanced:
- Timing matters enormously. Women who start HRT within 10 years of menopause onset (or before age 60) have a substantially different risk profile than women who start much later. The "timing hypothesis" is now well-supported: early initiation may actually be cardioprotective.
- Route of administration matters. Transdermal estrogen (patches, gels, creams) carries a much lower clot risk than oral estrogen, because it bypasses first-pass liver metabolism. Large observational studies show that transdermal routes are not associated with the elevated VTE (venous thromboembolism) risk seen with oral estradiol.
- Progesterone type matters. Micronized progesterone (bioidentical) carries a more favorable risk profile than synthetic progestins, particularly regarding breast cancer risk. Studies comparing the two suggest that progesterone type is a meaningful variable — not just an ideological preference.
- For most women in the right window, the benefits outweigh the risks. Bone protection, cardiovascular benefit, symptom relief, improved cognitive function and sleep — these are not trivial. The current clinical consensus among menopause specialists is that HRT is underused, not overused.
The problem isn't that women want hormones. The problem is that they want them without the infrastructure to use them safely — and that infrastructure has often failed them first.
The Reality Check: What DIY HRT Gets Right, and What It Gets Wrong
Women who go the DIY route are often right that they need hormone therapy. They're sometimes right that their doctor was too conservative. They're frequently correct about which hormones they need in general terms.
But the details are where it falls apart. Getting the right hormone is not the same as getting the right dose, the right delivery method, the right combination, and the right monitoring protocol. A 50mg progesterone OTC cream isn't doing the same job as 200mg micronized progesterone. A patch that's too high a dose isn't better than a patch that fits your biology. And without periodic labs, you have no feedback loop — you're adjusting based on how you feel, not what's actually happening in your bloodstream.
Feeling better is not the same as being safe.
Who Should Actually Be Considering Supervised HRT?
If you're asking yourself whether this is relevant to you, here's an honest profile of the person who typically benefits most from supervised hormone therapy:
- You're in perimenopause or postmenopause, typically between 40 and 65, experiencing symptoms that are affecting your quality of life (hot flashes, night sweats, sleep disruption, brain fog, mood changes, vaginal dryness)
- You're within 10 years of your last menstrual period, or under 60 — the window where the risk-benefit ratio is most favorable
- You don't have a current or recent hormone-receptor-positive breast cancer diagnosis
- You're willing to do baseline labs and follow-up testing to make sure the protocol is working and safe
- You want to understand your options — not just get a prescription handed to you without context
If you've been doing DIY HRT and it seems to be "working," supervised care is still worth pursuing — if only to confirm your dosing is appropriate and your endometrium is protected.
Risks and Side Effects: The Honest List
Supervised HRT isn't risk-free. Neither is leaving symptoms untreated. Here's what you need to know:
- Breast tenderness is common when starting, particularly with estrogen
- Spotting or irregular bleeding can occur, especially in perimenopause, and needs to be investigated if it persists
- Bloating, mood changes, or headaches are often dosing or timing issues that can be adjusted
- Small increase in breast cancer risk with long-term use (5+ years), though the absolute risk increase is small and varies by hormone type and individual history
- VTE risk is real with oral estrogen but substantially lower with transdermal delivery
- Endometrial hyperplasia risk with unopposed estrogen — eliminated with appropriate progesterone
The way you manage these risks is with monitoring — labs, periodic check-ins, and dose adjustments. That's not a sales pitch for supervision; it's literally how you keep the benefit-to-risk ratio in your favor.
What Supervised Hormone Therapy at Healthspan Actually Looks Like
If you've been managing your hormones alone because the clinical system failed you, Healthspan is a different kind of experience. It starts with your labs and your history, not a one-size-fits-all protocol.
Women's Hormone Health at Healthspan is a medically supervised program built around how your hormones actually look on paper — not assumptions based on your age or a checklist of symptoms. Here's what it includes:
- Baseline labs: Estradiol, FSH, progesterone, testosterone, SHBG, thyroid panel, and metabolic markers — so you start with a real picture of where you are
- Clinician consultation: A prescribing clinician reviews your labs, your symptom history, your risk factors, and your goals. You get a protocol designed for you, not a generic dose
- Access to bioidentical hormone options: Including Estradiol Patch, Micronized Progesterone, and Bi-Est 50/50 Cream — pharmaceutical-grade, not wellness-market cream of uncertain concentration
- Ongoing monitoring: Follow-up labs at regular intervals to confirm your levels are in the therapeutic range and adjust as needed
- Clinical oversight: If something changes — symptoms shift, labs look off, you want to adjust — you have a clinician to contact, not a forum thread
This is not concierge medicine that requires you to be wealthy. It's telehealth-delivered, which means accessible. And it's designed to be the answer for women who've been failed by the "wait and see" model and aren't willing to wing it alone anymore.
If you're ready to stop guessing and start with a protocol that's actually built around your biology, Women's Hormone Health is where to start.
Frequently Asked Questions About DIY HRT
Is DIY HRT illegal?
In most countries, purchasing prescription hormones without a valid prescription is illegal, even if you're ordering from an online pharmacy. OTC progesterone creams are legal but are not pharmaceutical-grade medications. The legal grey zone depends heavily on jurisdiction, and enforcement varies. Legality aside, the clinical risks of unmonitored hormone use are the more pressing concern for most women.
Are bioidentical hormones safer than synthetic HRT?
The evidence suggests that micronized progesterone (bioidentical) carries a more favorable risk profile than synthetic progestins, particularly regarding breast cancer and cardiovascular risk. Bioidentical estradiol and synthetic estradiol have similar safety profiles when matched for dose and route. "Bioidentical" is not a blanket safety certification — it means chemically identical to your own hormones, which is a meaningful distinction but not the whole story.
Can I use progesterone cream to protect my uterus while using estrogen?
Not reliably. Most OTC progesterone creams don't deliver sufficient systemic progesterone levels to adequately protect the endometrium from estrogen's proliferative effects. Studies show that transdermal cream absorption is highly variable and typically far below the levels needed for endometrial protection. Pharmaceutical-grade micronized progesterone, prescribed at the correct dose, is the clinically validated way to provide that protection if you have a uterus.
How do I know if my DIY HRT dose is correct?
Without labs, you don't. Symptoms are a rough guide but not a reliable measure — you can feel better at a dose that's still clinically insufficient, or feel fine at a dose that's driving your levels into a range that increases risk. Serum estradiol, progesterone, and sometimes SHBG testing give you an actual feedback loop. That's the only way to know if your dosing is in the therapeutic range.
What's the difference between perimenopause and menopause for HRT decisions?
Perimenopause (the transition phase, often beginning in the mid-40s) is characterized by fluctuating hormone levels, irregular cycles, and worsening symptoms. Menopause is defined as 12 consecutive months without a period. HRT in perimenopause typically needs to account for your body's own erratic hormone production, which makes dosing more complex. Postmenopause is generally more stable to manage hormonally. The protocols differ, which is another reason basing your approach on labs matters more than going by your age alone.
Does HRT cause breast cancer?
The relationship is more nuanced than the headlines have suggested. Combined estrogen-progestin HRT is associated with a small absolute increase in breast cancer risk with long-term use, but the type of progestogen matters — micronized progesterone appears to carry less risk than synthetic progestins. Estrogen-only HRT (for women without a uterus) is not clearly associated with increased risk and may even be slightly protective in some analyses. Individual risk factors, family history, and duration of use all affect the picture.
At what age should I start HRT?
The evidence supports starting HRT close to the onset of menopause symptoms, ideally within 10 years of your last period or before age 60 — what researchers call the "therapeutic window." Starting in this window is associated with cardiovascular benefits and better outcomes overall. Starting HRT for the first time at 65 or beyond carries a different risk calculation and requires more careful evaluation. Earlier is generally better if you have symptoms and no contraindications.
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials. JAMA. 2013;310(13):1353-1368. https://doi.org/10.1001/jama.2013.278040
- Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419-427. https://doi.org/10.1016/S0140-6736(03)14065-2
- Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens — the ESTHER study. Circulation. 2007;115(7):840-845. https://doi.org/10.1161/CIRCULATIONAHA.106.642280
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://doi.org/10.1136/bmj.k4810
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://doi.org/10.1007/s10549-007-9523-x
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://doi.org/10.1210/jc.2015-2236
- Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465-1477. https://doi.org/10.1001/jama.297.13.1465
- de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised Global Consensus Statement on Menopausal Hormone Therapy. Maturitas. 2016;91:153-155. https://doi.org/10.1016/j.maturitas.2016.06.001
- Scarabin PY. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis. Climacteric. 2018;21(4):341-345. https://doi.org/10.1080/13697137.2018.1446931
- Shifren JL, Gass ML; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038-1062. https://doi.org/10.1097/GME.0000000000000319